PROVIDER PROFILE · NPI 1194906693

Mark McdonnellMD

PRACTICEEDNA MA MD INCSee all providers at this practice →

Internal MedicineSylmar, CAI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

2,036

Beneficiaries

—

Total drug cost

$204K

Distinct drugs

Brand share

31.3%

Top prescribed drugs

Dabigatran Etexilate Mesylate261 claims

Atorvastatin Calcium255 claims

Carvedilol155 claims

Metoprolol Tartrate120 claims

Bisoprolol Fumarate105 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (2)

CCN 050686

Hospital

CCN 050765

Hospital

REFERRAL NETWORK

Where Mark Mcdonnell's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 1 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
KAISER FOUNDATION HOSPITALS	11	16

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
KAISER FOUNDATION HOSPITALS	20	25

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history